Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Kathleen Mary Ellen Gallagher, Ph.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gallagher KME, Leick MB, Larson RC, Berger TR, Katsis K, Yam JY, Maus MV. Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated Individuals. Clin Infect Dis. 2022 Aug 24; 75(1):e869-e873. PMID: 35278306; PMCID: PMC9402689.
    Citations:    Fields:    
  2. Atallah J, Archambault D, Randall JD, Shepro A, Styskal LE, Glenn DR, Connolly CB, Katsis K, Gallagher K, Ghebremichael M, Mansour MK. Rapid Quantum Magnetic IL-6 Point-of-Care Assay in Patients Hospitalized with COVID-19. Diagnostics (Basel). 2022 May 07; 12(5). PMID: 35626318; PMCID: PMC9139897.
  3. Masters NB, Mathis AD, Leung J, Raines K, Clemmons NS, Miele K, Balajee SA, Lanzieri TM, Marin M, Christensen DL, Clarke KR, Cruz MA, Gallagher K, Gearhart S, Gertz AM, Grady-Erickson O, Habrun CA, Kim G, Kinzer MH, Miko S, Oberste MS, Petras JK, Pieracci EG, Pray IW, Rosenblum HG, Ross JM, Rothney EE, Segaloff HE, Shepersky LV, Skrobarcek KA, Stadelman AM, Sumner KM, Waltenburg MA, Weinberg M, Worrell MC, Bessette NE, Peake LR, Vogt MP, Robinson M, Westergaard RP, Griesser RH, Icenogle JP, Crooke SN, Bankamp B, Stanley SE, Friedrichs PA, Fletcher LD, Zapata IA, Wolfe HO, Gandhi PH, Charles JY, Brown CM, Cetron MS, Pesik N, Knight NW, Alvarado-Ramy F, Bell M, Talley LE, Rotz LD, Rota PA, Sugerman DE, Gastañaduy PA. Public Health Actions to Control Measles Among Afghan Evacuees During Operation Allies Welcome - United States, September-November 2021. MMWR Morb Mortal Wkly Rep. 2022 Apr 29; 71(17):592-596. PMID: 35482557; PMCID: PMC9098237.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  4. Leick MB, Silva H, Scarfò I, Larson R, Choi BD, Bouffard AA, Gallagher K, Schmidts A, Bailey SR, Kann MC, Jan M, Wehrli M, Grauwet K, Horick N, Frigault MJ, Maus MV. Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia. Cancer Cell. 2022 05 09; 40(5):494-508.e5. PMID: 35452603; PMCID: PMC9107929.
    Citations: 1     Fields:    Translation:HumansCells
  5. Frigault MJ, Dietrich J, Gallagher K, Roschewski M, Jordan JT, Forst D, Plotkin SR, Cook D, Casey KS, Lindell KA, Depinho GD, Katsis K, Elder EL, Leick MB, Choi B, Horick N, Preffer F, Saylor M, McAfee S, O'Donnell PV, Spitzer TR, Dey B, DeFilipp Z, El-Jawahri A, Batchelor TT, Maus MV, Chen YB. Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial. Blood. 2022 04 14; 139(15):2306-2315. PMID: 35167655; PMCID: PMC9012129.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  6. Haydu JE, Maron JS, Redd RA, Gallagher KME, Fischinger S, Barnes JA, Hochberg EP, Johnson PC, Takvorian RW, Katsis K, Portman D, Ruiters J, Sechio S, Devlin M, Regan C, Blumenthal KG, Banerji A, Judd AD, Scorsune KJ, McGree BM, Sherburne MM, Lynch JM, Weitzman JI, Lei M, Kotton CN, Dighe AS, Maus MV, Alter G, Abramson JS, Soumerai JD. Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study. Blood Adv. 2022 03 22; 6(6):1671-1683. PMID: 35073571; PMCID: PMC8789382.
    Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
  7. Bailey SR, Vatsa S, Larson RC, Bouffard AA, Scarfò I, Kann MC, Berger TR, Leick MB, Wehrli M, Schmidts A, Silva H, Lindell KA, Demato A, Gallagher KME, Frigault MJ, Maus MV. Blockade or Deletion of IFN? Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies. Blood Cancer Discov. 2022 03 01; 3(2):136-153. PMID: 35015685.
    Citations: 5     Fields:    Translation:HumansCells
  8. How J, Gallagher KME, Liu Y, Katsis K, Elder EL, Larson RC, Leick MB, Neuberg D, Maus MV, Hobbs GS. Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients. Leukemia. 2022 04; 36(4):1176-1179. PMID: 35217807; PMCID: PMC8873343.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  9. Wehrli M, Gallagher K, Chen YB, Leick MB, McAfee SL, El-Jawahri AR, DeFilipp Z, Horick N, O'Donnell P, Spitzer T, Dey B, Cook D, Trailor M, Lindell K, Maus MV, Frigault MJ. Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS). J Immunother Cancer. 2022 01; 10(1). PMID: 34996813; PMCID: PMC8744112.
    Citations: 4     Fields:    Translation:Humans
  10. Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman LR, Chen DY, Gallagher KME, Bauer MR, Taylor HB, Dunn WA, Tarr C, Sidney J, Rachimi S, Conway HL, Katsis K, Wang Y, Leistritz-Edwards D, Durkin MR, Tomkins-Tinch CH, Finkel Y, Nachshon A, Gentili M, Rivera KD, Carulli IP, Chea VA, Chandrashekar A, Bozkus CC, Carrington M, Bhardwaj N, Barouch DH, Sette A, Maus MV, Rice CM, Clauser KR, Keskin DB, Pregibon DC, Hacohen N, Carr SA, Abelin JG, Saeed M, Sabeti PC. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell. 2021 07 22; 184(15):3962-3980.e17. PMID: 34171305; PMCID: PMC8173604.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  11. Gallagher KME, Leick MB, Larson RC, Berger TR, Katsis K, Yam JY, Brini G, Grauwet K, Maus MV. SARS -CoV-2 T-cell immunity to variants of concern following vaccination. bioRxiv. 2021 May 03. PMID: 33972942; PMCID: PMC8109204.
    Citations: 1     
  12. Johansson U, Gallagher K, Burgoyne V, Maus MV, Casey KS, Brini GG, Frigault MJ, Yam JY, Chavda N, Besley C, Lugthart S. Detection of CAR-T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories. Cytometry B Clin Cytom. 2021 11; 100(6):622-631. PMID: 33915021.
    Citations:    Fields:    Translation:Humans
  13. Kue J, Bersani A, Stevenson K, Yimer G, Wang SH, Gebreyes W, Hazim C, Westercamp M, Omondi M, Amare B, Alebachew G, Abubeker R, Fentaw S, Tigabu E, Kirley D, Vanderende D, Bancroft E, Gallagher KM, Kanter T, Balada-Llasat JM. Standardizing clinical culture specimen collection in Ethiopia: a training-of-trainers. BMC Med Educ. 2021 Apr 07; 21(1):195. PMID: 33827543.
    Citations:    Fields:    Translation:Humans
  14. Maryamchik E, Gallagher KME, Preffer FI, Kadauke S, Maus MV. New directions in chimeric antigen receptor T cell [CAR-T] therapy and related flow cytometry. Cytometry B Clin Cytom. 2020 07; 98(4):299-327. PMID: 32352629.
    Citations: 4     Fields:    Translation:HumansCells
  15. Schmidts A, Ormhøj M, Choi BD, Taylor AO, Bouffard AA, Scarfò I, Larson RC, Frigault MJ, Gallagher K, Castano AP, Riley LS, Cabral ML, Boroughs AC, Velasco Cárdenas RM, Schamel W, Zhou J, Mackay S, Tai YT, Anderson KC, Maus MV. Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Adv. 2019 11 12; 3(21):3248-3260. PMID: 31698455.
    Citations: 39     Fields:    Translation:HumansAnimalsCells
  16. Milne P, Wilhelm-Benartzi C, Grunwald MR, Bigley V, Dillon R, Freeman SD, Gallagher K, Publicover A, Pagan S, Marr H, Jones GL, Dickinson AM, Grech A, Burnett AK, Russell NH, Levis M, Knapper S, Collin M. Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia. Blood Adv. 2019 10 22; 3(20):3052-3061. PMID: 31648336.
    Citations: 6     Fields:    Translation:HumansCells
  17. Frigault MJ, Dietrich J, Martinez-Lage M, Leick M, Choi BD, DeFilipp Z, Chen YB, Abramson J, Crombie J, Armand P, Nayak L, Panzini C, Riley LS, Gallagher K, Maus MV. Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma. Blood. 2019 09 12; 134(11):860-866. PMID: 31320380; PMCID: PMC7022436.
    Citations: 57     Fields:    Translation:HumansCells
  18. Hazim C, Abubeker Ibrahim R, Westercamp M, Belete GA, Amare Kibret B, Kanter T, Yimer G, Adem TS, Stevenson KB, Urrego M, Kale KN, Omondi MW, VanderEnde D, Park BJ, Parsons MMB, Gallagher KM. Establishment of a Sentinel Laboratory-Based Antimicrobial Resistance Surveillance Network in Ethiopia. Health Secur. 2018; 16(S1):S30-S36. PMID: 30480505.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  19. Mersha AM, Braka F, Gallagher K, Tegegne AA, Argay AK, Mekonnen MA, Aragaw M, Abegaz DM, Worku EZ, Baynesagn MG. Measles burden in urban settings: characteristics of measles cases in Addis Ababa city administration, Ethiopia, 2004-2014. Pan Afr Med J. 2017; 27(Suppl 2):11. PMID: 28890752; PMCID: PMC5578724.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  20. Bedada SY, Gallagher K, Aregay AK, Mohammed B, Maalin MA, Hassen HA, Ali YM, Braka F, Kilebou PM. Assessment of source of information for polio supplementary immunization activities in 2014 and 2015, Somali, Ethiopia. Pan Afr Med J. 2017; 27(Suppl 2):7. PMID: 28983395; PMCID: PMC5619920.
    Citations:    Fields:    Translation:HumansPHPublic Health
  21. Getahun M, Beyene B, Ademe A, Teshome B, Tefera M, Asha A, Afework A, HaileMariyam Y, Assefa E, Gallagher K. Epidemiology of laboratory confirmed measles virus cases in Amhara Regional State of Ethiopia, 2004-2014. BMC Infect Dis. 2016 Mar 22; 16:133. PMID: 27001744; PMCID: PMC4802717.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  22. Kutty PK, Lawler J, Rausch-Phung E, Ortega-Sanchez IR, Goodell S, Schulte C, Pollock L, Valure B, Hudson J, Gallagher K, Blog D. Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010. Hum Vaccin Immunother. 2014; 10(5):1373-81. PMID: 24633360.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  23. Adams DA, Gallagher KM, Jajosky RA, Kriseman J, Sharp P, Anderson WJ, Aranas AE, Mayes M, Wodajo MS, Onweh DH, Abellera JP. Summary of Notifiable Diseases - United States, 2011. MMWR Morb Mortal Wkly Rep. 2013 Jul 05; 60(53):1-117. PMID: 23820934.
    Citations: 45     Fields:    Translation:HumansPHPublic Health
  24. Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, Lizama A, Diras D, Mathew A, Camacho EJ, Monforte MN, Chen TH, Mahamud A, Kutty PK, Hickman C, Bellini WJ, Seward JF, Gallagher K, Fiebelkorn AP. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010. Pediatr Infect Dis J. 2013 Apr; 32(4):374-80. PMID: 23099425; PMCID: PMC6893844.
    Citations: 35     Fields:    Translation:HumansPHPublic Health
  25. Fiebelkorn AP, Rosen JB, Brown C, Zimmerman CM, Renshowitz H, D'Andrea C, Gallagher KM, Harpaz R, Zucker JR. Environmental factors potentially associated with mumps transmission in yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010. Hum Vaccin Immunother. 2013 Jan; 9(1):189-94. PMID: 23442590.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  26. Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, Schulte C, Valure B, Armstrong GL, Gallagher K. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics. 2012 Dec; 130(6):e1567-74. PMID: 23129075.
    Citations: 34     Fields:    Translation:HumansPHPublic Health
  27. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, Apostolou A, Blog D, Zimmerman CM, Montana B, Harpaz R, Hickman CJ, Rota PA, Rota JS, Bellini WJ, Gallagher KM. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med. 2012 11 01; 367(18):1704-13. PMID: 23113481.
    Citations: 53     Fields:    Translation:HumansPHPublic Health
  28. Abedi GR, Mutuc JD, Lawler J, Leroy ZC, Hudson JM, Blog DS, Schulte CR, Rausch-Phung E, Ogbuanu IU, Gallagher K, Kutty PK. Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak. Vaccine. 2012 Nov 19; 30(49):7052-8. PMID: 23041123.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  29. Mahamud A, Fiebelkorn AP, Nelson G, Aguon A, McKenna J, Villarruel G, Gallagher K, Ortega-Sánchez IR. Economic impact of the 2009-2010 Guam mumps outbreak on the public health sector and affected families. Vaccine. 2012 Oct 05; 30(45):6444-8. PMID: 22902678.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  30. Pembroke T, Rees I, Gallagher K, Jones E, Mizen P, Navruzov T, Freedman A, Fielding C, Humphreys IR, Wang EC, Gallimore AM, Godkin A. Rapid early innate control of hepatitis C virus during IFN-a treatment compromises adaptive CD4+ T-cell immunity. Eur J Immunol. 2012 Sep; 42(9):2383-94. PMID: 22653709; PMCID: PMC3781703.
    Citations: 6     Fields:    Translation:HumansCells
  31. Cole DK, Gallagher K, Lemercier B, Holland CJ, Junaid S, Hindley JP, Wynn KK, Gostick E, Sewell AK, Gallimore AM, Ladell K, Price DA, Gougeon ML, Godkin A. Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4? T-cell repertoire selection. Nat Commun. 2012 Feb 07; 3:665. PMID: 22314361.
    Citations: 20     Fields:    Translation:HumansCells
  32. Thompson KM, Wallace GS, Tebbens RJ, Smith PJ, Barskey AE, Pallansch MA, Gallagher KM, Alexander JP, Armstrong GL, Cochi SL, Wassilak SG. Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response. Public Health Rep. 2012 Jan-Feb; 127(1):23-37. PMID: 22298920; PMCID: PMC3234395.
    Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
  33. Kim C, Chavez P, Pierce A, Murray A, Sander M, Kenyon C, Sharangpani R, Abernathy E, Icenogle J, Kutty PK, Redd SB, Gallagher K, Neatherlin J, Marienau K. Rubella contact tracing associated with air travel. Travel Med Infect Dis. 2012 Jan; 10(1):48-51. PMID: 22212199.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  34. Klevens RM, Kruszon-Moran D, Wasley A, Gallagher K, McQuillan GM, Kuhnert W, Teshale EH, Drobeniuc J, Bell BP. Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey. Public Health Rep. 2011 Jul-Aug; 126(4):522-32. PMID: 21800746; PMCID: PMC3115211.
    Citations: 14     Fields:    Translation:Humans
  35. Latner DR, McGrew M, Williams N, Lowe L, Werman R, Warnock E, Gallagher K, Doyle P, Smole S, Lett S, Cocoros N, DeMaria A, Konomi R, Brown CJ, Rota PA, Bellini WJ, Hickman CJ. Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis. Clin Vaccine Immunol. 2011 Jan; 18(1):35-42. PMID: 21047998.
    Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
  36. Fiebelkorn AP, Redd SB, Gallagher K, Rota PA, Rota J, Bellini W, Seward J. Measles in the United States during the postelimination era. J Infect Dis. 2010 Nov 15; 202(10):1520-8. PMID: 20929352.
    Citations: 45     Fields:    Translation:HumansPHPublic Health
  37. Patel P, Mackellar D, Simmons P, Uniyal A, Gallagher K, Bennett B, Sullivan TJ, Kowalski A, Parker MM, LaLota M, Kerndt P, Sullivan PS. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med. 2010 Jan 11; 170(1):66-74. PMID: 20065201.
    Citations: 42     Fields:    Translation:Humans
  38. Klevens RM, Miller J, Vonderwahl C, Speers S, Alelis K, Sweet K, Rocchio E, Poissant T, Vogt TM, Gallagher K. Population-based surveillance for hepatitis C virus, United States, 2006-2007. Emerg Infect Dis. 2009 Sep; 15(9):1499-502. PMID: 19788825.
    Citations: 22     Fields:    Translation:HumansPHPublic Health
  39. Roberts GW, Baird D, Gallagher K, Jones RE, Pepper CJ, Williams JD, Topley N. Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis. J Am Soc Nephrol. 2009 Sep; 20(9):1895-900. PMID: 19713313.
    Citations: 15     Fields:    Translation:HumansCells
  40. Gallagher KM, Lauder S, Rees IW, Gallimore AM, Godkin AJ. Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen. J Immunol. 2009 Sep 01; 183(5):2915-20. PMID: 19667099.
    Citations: 23     Fields:    Translation:HumansCells
  41. Grytdal SP, Liao Y, Chen R, Garvin CC, Grigg-Saito D, Kagawa-Singer M, Liang S, McPhee SJ, Nguyen TT, Tran JH, Gallagher KM. Hepatitis B testing and vaccination among Vietnamese- and Cambodian-Americans. J Community Health. 2009 Jun; 34(3):173-80. PMID: 19234773.
    Citations: 25     Fields:    Translation:HumansPHPublic Health
  42. Sivasankar B, Longhi MP, Gallagher KM, Betts GJ, Morgan BP, Godkin AJ, Gallimore AM. CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy? J Immunol. 2009 May 01; 182(9):5203-7. PMID: 19380765; PMCID: PMC2704398.
    Citations: 20     Fields:    Translation:HumansCells
  43. Lissina A, Ladell K, Skowera A, Clement M, Edwards E, Seggewiss R, van den Berg HA, Gostick E, Gallagher K, Jones E, Melenhorst JJ, Godkin AJ, Peakman M, Price DA, Sewell AK, Wooldridge L. Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. J Immunol Methods. 2009 Jan 01; 340(1):11-24. PMID: 18929568; PMCID: PMC3052435.
    Citations: 70     Fields:    Translation:HumansAnimalsCells
  44. Wasley A, Grytdal S, Gallagher K. Surveillance for acute viral hepatitis--United States, 2006. MMWR Surveill Summ. 2008 Mar 21; 57(2):1-24. PMID: 18354374.
    Citations: 73     Fields:    Translation:HumansPHPublic Health
  45. Godkin A, Ng WF, Gallagher K, Betts G, Thomas HC, Lechler RI. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage? J Allergy Clin Immunol. 2008 May; 121(5):1277-1284.e3. PMID: 18355912.
    Citations: 9     Fields:    Translation:HumansCells
  46. Gallagher KM, Juhasz M, Harris NS, Teshale EH. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. J Infect Dis. 2007 Aug 01; 196(3):339-46. PMID: 17597447.
    Citations: 12     Fields:    Translation:Humans
  47. Gallagher KME, Man S. Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women. J Gen Virol. 2007 May; 88(Pt 5):1470-1478. PMID: 17412975.
    Citations: 12     Fields:    Translation:HumansCells
  48. Gallagher KM, Denning PD, Allen DR, Nakashima AK, Sullivan PS. Use of rapid behavioral assessments to determine the prevalence of HIV risk behaviors in high-risk populations. Public Health Rep. 2007; 122 Suppl 1:56-62. PMID: 17354528; PMCID: PMC1804112.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  49. Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep. 2007; 122 Suppl 1:32-8. PMID: 17354525; PMCID: PMC1804113.
    Citations: 131     Fields:    Translation:HumansPHPublic Health
  50. MacKellar DA, Gallagher KM, Finlayson T, Sanchez T, Lansky A, Sullivan PS. Surveillance of HIV risk and prevention behaviors of men who have sex with men--a national application of venue-based, time-space sampling. Public Health Rep. 2007; 122 Suppl 1:39-47. PMID: 17354526; PMCID: PMC1804106.
    Citations: 191     Fields:    Translation:HumansPHPublic Health
  51. Lansky A, Sullivan PS, Gallagher KM, Fleming PL. HIV behavioral surveillance in the U.S.: a conceptual framework. Public Health Rep. 2007; 122 Suppl 1:16-23. PMID: 17354523; PMCID: PMC1804114.
    Citations: 34     Fields:    Translation:HumansPHPublic Health
  52. Sanchez TH, Gallagher KM. Factors associated with recent sildenafil (viagra) use among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2006 May; 42(1):95-100. PMID: 16763497.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  53. Lansky A, MacKellar D, Gallagher KM, Lin LS, Sullivan PS, Onorato IM. Evaluation of the new National HIV Behavioral Surveillance System (NHBS) is imperative. Sex Transm Dis. 2006 Apr; 33(4):272-3; author reply 274-5. PMID: 16565646.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  54. Ciesielski C, Kahn RH, Taylor M, Gallagher K, Prescott LJ, Arrowsmith S. Control of syphilis outbreaks in men who have sex with men: the role of screening in nonmedical settings. Sex Transm Dis. 2005 Oct; 32(10 Suppl):S37-42. PMID: 16205290; PMCID: PMC6786262.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  55. Blank S, Gallagher K, Washburn K, Rogers M. Reaching out to boys at bars: utilizing community partnerships to employ a wellness strategy for syphilis control among men who have sex with men in New York City. Sex Transm Dis. 2005 Oct; 32(10 Suppl):S65-72. PMID: 16205296.
    Citations: 16     Fields:    Translation:Humans
  56. Heffernan RT, Barrett NL, Gallagher KM, Hadler JL, Harrison LH, Reingold AL, Khoshnood K, Holford TR, Schuchat A. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis. 2005 Jun 15; 191(12):2038-45. PMID: 15897989.
    Citations: 57     Fields:    Translation:Humans
  57. Smith KL, Tristram A, Gallagher KM, Fiander AN, Man S. Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18. Int Immunol. 2005 Feb; 17(2):167-76. PMID: 15623547; PMCID: PMC7109653.
    Citations: 10     Fields:    Translation:HumansCells
  58. Gallagher KM, Jara M, Demaria A, Seage GR, Heeren T. The reliability of passively collected AIDS surveillance data in Massachusetts. Ann Epidemiol. 2003 Feb; 13(2):100-4. PMID: 12559668.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  59. Jara MM, Gallagher KM, Schieman S. Estimation of completeness of AIDS case reporting in Massachusetts. Epidemiology. 2000 Mar; 11(2):209-13. PMID: 11021621.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  60. Lebow JM, O'Connell JJ, Oddleifson S, Gallagher KM, Seage GR, Freedberg KA. AIDS among the homeless of Boston: a cohort study. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 01; 8(3):292-6. PMID: 7859142.
    Citations: 4     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gallagher's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (281)
Co-Authors (49)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.